|
|
|
|
||
Anyone have opinions on Niacin article in NEJM And how it could impact V sales? On one hand more potential customers, however, I worry that some may tar V with the idea that since it lowers trigs like Niacin and lowers APOC-3 like Niacin that docs may be leery? Really hoping this is good news and management and sales know how to leverage this info on Niacin to increase sales but not knowledgeable enough to know how this info will be perceived vis-s-vis Vascepa. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
1569 | Re: Anyone have opinions on Niacin article in NEJM | ex_hacker202 | 2 | 7/18/2014 1:51:46 PM |
1570 | Re: Anyone have opinions on Niacin article in NEJM | cmm3rd | 3 | 7/18/2014 11:02:42 PM |